🔗 Permalink

Assignee profile:

Immunic AG

City:

Gräfelfing

Country:

Germany

Published Applications:

Last publication date:

2025-05-01

Patent Grants:

Last grant date:

2025-10-07

Top Inventors for applications by Immunic AG

These are the the leading inventors for applications assigned to Immunic AG:

Daniel VITT 10 Germering, Germany
Hella KOHLHOF 9 Munich, Germany
Andreas MÜHLER 8 Munich, Germany
Andreas Mühler 7 Munich, Germany

Manfred GRÖPPEL 4 Erlangen, Germany
Manfred Gröppel 3 Erlangen, Germany
Manfred GRÖPPEL 2 Munich, Germany
Manfred GROPPEL 2 Munich, Germany

Hella KOHLHOF 1 Munchen, Germany
Andreas MÜHLER 1 München, Germany
Christian Gege 1 Ehingen, Germany

Recent patent applications by Immunic AG

Immunic AG based in Gräfelfing, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-05-01

US20250136542A1

Chemistry; metallurgy

CALCIUM SALT POLYMORPHS AS ANTI-INFLAMMATORY, IMMUNODULATORY AND ANTI-PROLIFERATIVE AGENTS

#2 | 2025-04-17

US20250120931A1

Human necessities

TREATMENT OF MULTIPLE SCHLEROSIS COMPRISING DHODH INHIBITORS

#3 | 2024-06-20

US20240199535A1

Chemistry; metallurgy

DEUTERATED DHODH INHIBITORS

#4 | 2024-06-06 ✅ Patent 12,433,860 granted on 2025-10-07

US20240180858A1

Human necessities

Treatment of Multiple Sclerosis Comprising DHODH Inhibitors

#5 | 2024-03-28 ✅ Patent 12,629,347 granted on 2026-05-19

US20240100005A1

Human necessities

Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases

#6 | 2023-04-13 ✅ Patent 11,877,995 granted on 2024-01-23

US20230116729A1

Human necessities

Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases

#7 | 2023-02-16 ✅ Patent 11,877,994 granted on 2024-01-23

US20230051911A1

Human necessities

Treatment of multiple sclerosis comprising DHODH inhibitors

#8 | 2022-10-27 ✅ Patent 12,167,994 granted on 2024-12-17

US20220339132A1

Human necessities

Vidofludimus for use in the treatment or prevention of viral diseases

#9 | 2021-10-21 ✅ Patent 11,376,232 granted on 2022-07-05

US20210322351A1

Human necessities

Vidofludimus for use in the treatment or prevention of viral diseases

#10 | 2021-01-21 ✅ Patent 12,037,305 granted on 2024-07-16

US20210017125A1

Chemistry; metallurgy

Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents

Also check out Immunic AG's (Gräfelfing, Germany) applicant profile with 17 patent applications submitted.

AssigneeID:

306571 ⎘